相关实验视频

Updated: Jun 26, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

新血管与年龄相关的黄斑变性中的基因疗法:最新情况

Erika Quesada¹, Sofía Rojas¹, Xiomara Campos¹

¹Asociados de Mácula, Vítreo y Retina de Costa Rica, Primer Piso Torre Mercedes Paseo Colón, San José, Costa Rica.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

|April 28, 2025

概括

基因疗法为新血管与年龄相关的黄斑变性 (NV-AMD) 的当前治疗提供了一个有希望的替代方案,可能会改善结果. 虽然存在风险,但正在进行的对RGX-314和4D-150等遗传治疗的研究显示了未来NV-AMD管理的潜力.

科学领域:

眼科医生眼科眼科
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

神经血管与年龄相关的黄斑变性 (NV-AMD) 是老年人视力丧失的主要原因.
目前的治疗方法,如内抗VEGF注射,是有效的,但繁的,导致合规问题和低于最佳的视觉结果.

研究的目的:

探索基因疗法作为NV-AMD的新型治疗策略.
审查目前的基因疗法方法和NV-AMD治疗的潜在未来方向.

主要方法:

对NV-AMD当前基因治疗策略的审查,重点是转基因输送抗血管原蛋白.
讨论主要的基因治疗方案,包括Ixoberogene soroparvovec,RGX-314和4D-150.
探索潜在的未来应用,例如基于CRISPR的基因组手术.

主要成果:

基因疗法旨在通过输送表达抗血管原蛋白的转基因来抑制VEGF途径.
一些领先的基因治疗方案正在为NV-AMD开发.
临床前研究表明使用CRISPR技术进行基因组手术的潜力.

结论:

基因疗法为NV-AMD的标准治疗提供了一个有希望的替代方案,可能克服合规问题.
与基因疗法相关的潜在风险包括免疫反应和插入性突变发生.
像CRISPR这样的先进技术可能为NV-AMD提供未来的治疗途径.

关键词:

4D-150是什么意思? 4D-150是什么意思?一个自由的概念.与年龄相关的黄斑变性.基因治疗是一种基因疗法.伊克索贝罗基因 (Ixoberogene) 是一种可怕的物质.在RGX-31414中使用.拉尼比祖马姆是什么意思蔬菜蔬菜蔬菜

更多相关视频

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.